Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.

Tuba Kurt Fatma Aydın Pakize Nilüfer Tekgöz Müge Sezer Nermin Uncu Banu Çelikel Acar

Published in: International journal of rheumatic diseases (2020)

Anti-IL-1 treatment is quite effective in children with colchicine-resistant FMF patients, proven with improved AIDAI scores and school attendance rates. In the long term by lowering disease activation even development of amyloidosis may be prevented.

Keyphrases

end stage renal disease
young adults
ejection fraction
mental health
physical activity
prognostic factors
peritoneal dialysis
multiple myeloma